These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 31487964)

  • 1. Exosomes in Systemic Sclerosis: Messengers Between Immune, Vascular and Fibrotic Components?
    Colletti M; Galardi A; De Santis M; Guidelli GM; Di Giannatale A; Di Luigi L; Antinozzi C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487964
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered expression of CD63 and exosomes in scleroderma dermal fibroblasts.
    Nakamura K; Jinnin M; Harada M; Kudo H; Nakayama W; Inoue K; Ogata A; Kajihara I; Fukushima S; Ihn H
    J Dermatol Sci; 2016 Oct; 84(1):30-39. PubMed ID: 27443953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes isolated from serum of systemic sclerosis patients display alterations in their content of profibrotic and antifibrotic microRNA and induce a profibrotic phenotype in cultured normal dermal fibroblasts.
    Wermuth PJ; Piera-Velazquez S; Jimenez SA
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):21-30. PubMed ID: 28094758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma.
    Zhu H; Luo H; Zuo X
    Exp Mol Med; 2013 Sep; 45(9):e41. PubMed ID: 24052166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probable role of exosomes in the extension of fibrotic alterations from affected to normal cells in systemic sclerosis.
    Jimenez SA; Piera-Velazquez S
    Rheumatology (Oxford); 2023 Mar; 62(3):999-1008. PubMed ID: 35944210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
    Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
    Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy.
    Henry TW; Mendoza FA; Jimenez SA
    Autoimmun Rev; 2019 Nov; 18(11):102396. PubMed ID: 31520794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis.
    Luo Y; Wang Y; Shu Y; Lu Q; Xiao R
    Int J Biochem Cell Biol; 2015 Oct; 67():92-100. PubMed ID: 26043891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Alarmins in the Pathogenesis of Systemic Sclerosis.
    Giovannetti A; Straface E; Rosato E; Casciaro M; Pioggia G; Gangemi S
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment.
    Affandi AJ; Radstake TR; Marut W
    Semin Immunopathol; 2015 Sep; 37(5):475-87. PubMed ID: 26168983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T Cells in Systemic Sclerosis.
    Frantz C; Auffray C; Avouac J; Allanore Y
    Front Immunol; 2018; 9():2356. PubMed ID: 30374354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of scleroderma: lessons from transgenic and knockout mice.
    Derrett-Smith EC; Denton CP; Sonnylal S
    Curr Opin Rheumatol; 2009 Nov; 21(6):630-5. PubMed ID: 19730378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferon dysregulation in Systemic Sclerosis.
    Skaug B; Assassi S
    Cytokine; 2020 Aug; 132():154635. PubMed ID: 30685202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of metabolism in the pathogenesis of systemic sclerosis.
    Zhu H; Chen W; Liu D; Luo H
    Metabolism; 2019 Apr; 93():44-51. PubMed ID: 30586574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines in the immunopathology of systemic sclerosis.
    Raja J; Denton CP
    Semin Immunopathol; 2015 Sep; 37(5):543-57. PubMed ID: 26152640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging roles of exosomes in autoimmune diseases, with special emphasis on microRNAs in exosomes.
    Miao C; Wang X; Zhou W; Huang J
    Pharmacol Res; 2021 Jul; 169():105680. PubMed ID: 34010670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early inflammatory players in cutanous fibrosis.
    Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
    J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
    Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic sclerosis.
    Asano Y
    J Dermatol; 2018 Feb; 45(2):128-138. PubMed ID: 29226387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances on pathogenesis and therapies in systemic sclerosis.
    Yazawa N; Fujimoto M; Tamaki K
    Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):107-12. PubMed ID: 18064573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.